(Q45265094)

English

Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors

scientific article published on 14 February 2005

Statements

Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors (English)
Federico Vázquez
Anne Van Vreckem
Joaquim Bellmunt
James A Manning
Mónica García

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit